Updates in the diagnosis and management of non-ampullary small-bowel polyposis

Laura Lucaciu1, Tomonori Yano2, Jean Christophe Saurin3

  • 1Royal Free Unit for Endoscopy, The Royal Free Hospital and UCL Institute for Liver and Digestive Health, London, UK.

Insights

Gastrointestinal surveillance for Peutz-Jeghers syndrome should start by age eight. Small bowel polyps over 15 mm require treatment to prevent intussusception, with new endoscopic techniques emerging.

Area of Science:

  • Gastroenterology
  • Endoscopic Surgery
  • Hereditary Gastrointestinal Polyposis Syndromes

Background:

  • Advances in endoscopic technology have transformed the diagnosis and management of non-ampullary small-bowel polyposis.
  • Hereditary polyposis syndromes, including Peutz-Jeghers syndrome (PJS), familial adenomatous polyposis (FAP), and juvenile polyposis syndrome (JPS), present unique challenges in small bowel surveillance and management.

Purpose of the Study:

  • To provide an updated overview of the diagnostic and management strategies for non-ampullary small-bowel polyposis, focusing on hereditary polyposis syndromes.
  • To highlight current recommendations for endoscopic surveillance intervals and polyp resection thresholds based on syndrome type and polyp size.

Main Methods:

  • Review of current literature and guidelines regarding endoscopic surveillance and management of small bowel polyps in PJS, FAP, and JPS.
  • Discussion of emerging endoscopic techniques such as ischemic polypectomy and endoscopic reduction of intussusception.

Main Results:

  • For PJS, capsule endoscopy surveillance should begin by age eight, with polyps >15 mm requiring treatment to prevent intussusception.
  • For FAP, initial screening of the proximal jejunum is recommended around age 25, with individualized duodenal surveillance intervals; resection of adenomas >1 cm is advised.
  • Small bowel involvement in JPS is infrequent and primarily duodenal, without indication for distal small bowel investigation.

Conclusions:

  • Tailored endoscopic surveillance and timely intervention are crucial for managing small bowel polyposis in hereditary syndromes.
  • Emerging endoscopic techniques offer promising alternatives for polyp management and complication prevention.
  • Adherence to syndrome-specific guidelines and consideration of polyp characteristics are essential for optimal patient outcomes.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
167
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
354
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
98
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
191
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
152
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
113